LifeStance Health Group, Inc. has disclosed a substantial stock sale by its director, Kenneth Burdick. The transaction, reported in an SEC filing, involved the sale of 66,589 shares valued at approximately $959,715.86. This sale is significant as it reflects ongoing trends in the health services sector, where insider transactions can impact investor sentiment and market dynamics.
LifeStance Health Group, Inc., categorized under the SIC code 8000 for health services, operates within the Nasdaq exchange under the ticker LFST. The company is a large accelerated filer and is based in Scottsdale, Arizona. The recent filing, dated November 9, 2026, is part of a series of disclosures made by the company, including multiple Form 4 filings and a Schedule 13G/A.
The SEC filing indicates that Burdick sold the shares on November 9, 2026, following a series of restricted stock vesting transactions. Specifically, he acquired 11,386 shares on March 7, 2025, and 55,203 shares on March 8, 2025, as part of his compensation package. The filing notes that Burdick had previously sold 500,000 shares on August 11, 2026, for gross proceeds of approximately $5.76 million.
This recent sale may affect various stakeholders, including investors, employees, and analysts monitoring the company's stock performance and insider trading activities. Such transactions are common in the health services industry, where executive compensation often includes stock options and restricted shares that executives may sell as they vest.
As for what’s next, the filing does not specify any forthcoming actions or additional disclosures related to this transaction. Investors and market watchers will likely continue to monitor LifeStance Health Group for further updates and filings.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










